Latest News

Celltrion Finalizes Clinical Trials for Remsima SC, Planning to File a Marketing Authorization Application to the EMA in H2

INCHEON, South Korea–(BUSINESS WIRE)–#Celltrion–Celltrion finalizes clinical trials for the patient convenience-enhanced Remsima SC, planning to file a marketing authorization application to the EMA

Source link

Related posts



Senza Omnia Stimulator for Chronic Pain, with Widest Frequency Range, FDA Approved


Cellular Incubator for Implantation Into Body


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World